InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,124.03
(
-0.10%
)
Post# of 1367
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: midastouch017 post# 1155

Sunday, 10/21/2012 3:52:28 AM

Sunday, October 21, 2012 3:52:28 AM

Post# of 1367
I assume this piece triggered your question:

http://www.globes.co.il/serveen/globes/docview.asp?did=1000791112&fid=1725

Of course, a faster and cheaper clinical path would be good for any drug developing company, but note that Dr. Hamburg said the agency is considering a faster track for drugs with "special medical use" label. Don't know when a guideline will be issued and if one of PSTI's treatments qualifies at all.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up